Skip to main content
Erschienen in: International Urology and Nephrology 2/2018

18.11.2017 | Nephrology - Original Paper

From bench to the hemodialysis clinic: protein-bound uremic toxins modulate NF-κB/Nrf2 expression

verfasst von: Milena B. Stockler-Pinto, Christophe O. Soulage, Natália A. Borges, Ludmila F. M. F. Cardozo, Carla J. Dolenga, Lia S. Nakao, Roberto Pecoits-Filho, Denis Fouque, Denise Mafra

Erschienen in: International Urology and Nephrology | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Uremic toxins produced by gut microbiota (indoxyl sulfate—IS, p-cresyl sulfate—p-CS, and indole-3-acetic acid—IAA) accumulate in hemodialysis (HD) patients and exhibit potent inflammatory effects. However, the impact of these toxins on nuclear E2-related factor 2 (Nrf2) and nuclear factor-kappa B (NF-κB) expression in HD patients remains poorly defined. The aim of this study was to evaluate the association between uremic toxins and Nrf2/NF-κB expression in vitro (RAW 264.7 macrophage-like cells) and in peripheral blood mononuclear cells from HD patients.

Methods

Uremic toxins, C-reactive protein (CRP), interleukin-6 (IL-6) and malondialdehyde (MDA) levels were measured in fifteen HD patients and nine healthy individuals. RAW 264.7 macrophage-like cells were incubated with IS, as a prototype of protein-bound uremic toxin. Nrf2 and NF-κB expressions were analyzed by RT-qPCR.

Results

HD patients presented high levels of inflammatory markers, MDA and uremic toxins. In addition, they presented high NF-κB and low Nrf2 expression. Uremic toxins were positively correlated with NF-κB expression (IS, ρ = 0.58, p < 0.003; p-CS, ρ = 0.71, p < 0.001; IAA, ρ = 0.62, p < 0.001) and negatively with Nrf2 (IS, ρ = − 0.48, p = 0.01; p-CS, ρ = − 0.46, p < 0.02). Uremic toxins also exhibited positive correlations with CRP and MDA levels. Multivariate analysis revealed that p-CS is a determinant factor of NF-κB expression. In RAW 264.7 culture, NF-κB mRNA expression was stimulated by IS, while Nrf2 was downregulated.

Conclusions

Thus, uremic toxins may stimulate NF-κB mRNA and decrease Nrf2 expression in HD patients and, consequently, trigger inflammation and oxidative stress.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Meijers BK, Evenepoel P (2011) The gut-kidney axis: indoxyl sulfate, p-cresyl sulfate and CKD progression. Nephrol Dial Transplant 26:759–761CrossRefPubMed Meijers BK, Evenepoel P (2011) The gut-kidney axis: indoxyl sulfate, p-cresyl sulfate and CKD progression. Nephrol Dial Transplant 26:759–761CrossRefPubMed
2.
Zurück zum Zitat Mafra D, Lobo JC, Barros AF, Koppe L, Vaziri ND, Fouque D (2014) Role of altered intestinal microbiota in systemic inflammation and cardiovascular disease in chronic kidney disease. Future Microbiol 9(3):399–410CrossRefPubMed Mafra D, Lobo JC, Barros AF, Koppe L, Vaziri ND, Fouque D (2014) Role of altered intestinal microbiota in systemic inflammation and cardiovascular disease in chronic kidney disease. Future Microbiol 9(3):399–410CrossRefPubMed
3.
Zurück zum Zitat Deltombe O, Biesen WV, Glorieux G, Massy Z, Dhondt A, Eloot S (2015) Exploring protein binding of uremic toxins in patients with different stages of chronic kidney disease and during hemodialysis. Toxins 7:3933–3946CrossRefPubMedPubMedCentral Deltombe O, Biesen WV, Glorieux G, Massy Z, Dhondt A, Eloot S (2015) Exploring protein binding of uremic toxins in patients with different stages of chronic kidney disease and during hemodialysis. Toxins 7:3933–3946CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Stockler-Pinto MB, Saldanha JF, Yi D, Mafra D, Fouque D, Soulage CO (2016) The uremic toxin indoxyl sulfate exacerbates reactive oxygen species production and inflammation in 3T3-L1 adipose cells. Free Radic Res 50(3):337–344CrossRefPubMed Stockler-Pinto MB, Saldanha JF, Yi D, Mafra D, Fouque D, Soulage CO (2016) The uremic toxin indoxyl sulfate exacerbates reactive oxygen species production and inflammation in 3T3-L1 adipose cells. Free Radic Res 50(3):337–344CrossRefPubMed
5.
Zurück zum Zitat Sallée M, Dou L, Cerini C, Poitevin S, Brunet P, Burtey S (2014) The aryl hydrocarbon receptor-activating effect of uremic toxins from tryptophan metabolism: a new concept to understand cardiovascular complications of chronic kidney disease. Toxins 6:934–949CrossRefPubMedPubMedCentral Sallée M, Dou L, Cerini C, Poitevin S, Brunet P, Burtey S (2014) The aryl hydrocarbon receptor-activating effect of uremic toxins from tryptophan metabolism: a new concept to understand cardiovascular complications of chronic kidney disease. Toxins 6:934–949CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Lee WC, Li LC, Chen JB, Chang HW (2015) Indoxyl sulfate-induced oxidative stress, mitochondrial dysfunction, and impaired biogenesis are partly protected by vitamin C and N-acetylcysteine. Sci World J 2015:1–6 Lee WC, Li LC, Chen JB, Chang HW (2015) Indoxyl sulfate-induced oxidative stress, mitochondrial dysfunction, and impaired biogenesis are partly protected by vitamin C and N-acetylcysteine. Sci World J 2015:1–6
7.
Zurück zum Zitat Tang WH, Wang CP, Chung FM, Huang LL, Yu TH, Hung WC et al (2015) Uremic retention solute indoxyl sulfate level is associated with prolonged QTc interval in early CKD patients. PLoS ONE 10(3):e0119545CrossRefPubMedPubMedCentral Tang WH, Wang CP, Chung FM, Huang LL, Yu TH, Hung WC et al (2015) Uremic retention solute indoxyl sulfate level is associated with prolonged QTc interval in early CKD patients. PLoS ONE 10(3):e0119545CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Poesen R, Windey K, Neven E, Kuypers D, De Preter V, Augustijns P et al (2015) The influence of CKD on colonic microbial metabolism. J Am Soc Nephrol 27(5):1389–1399CrossRefPubMedPubMedCentral Poesen R, Windey K, Neven E, Kuypers D, De Preter V, Augustijns P et al (2015) The influence of CKD on colonic microbial metabolism. J Am Soc Nephrol 27(5):1389–1399CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Gao C, Ji S, Dong W, Qi Y, Song W, Cui D, Shi J (2015) Indolic uremic solutes enhance procoagulant activity of red blood cells through phosphatidylserine exposure and microparticle release. Toxins 7:4390–4403CrossRefPubMedPubMedCentral Gao C, Ji S, Dong W, Qi Y, Song W, Cui D, Shi J (2015) Indolic uremic solutes enhance procoagulant activity of red blood cells through phosphatidylserine exposure and microparticle release. Toxins 7:4390–4403CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Jourde-Chiche N, Dou L, Cerini C, Dignat-George F, Vanholder R, Brunet P (2009) Protein-bound toxin—update 2009. Semin Dial 22(4):334–339CrossRefPubMed Jourde-Chiche N, Dou L, Cerini C, Dignat-George F, Vanholder R, Brunet P (2009) Protein-bound toxin—update 2009. Semin Dial 22(4):334–339CrossRefPubMed
11.
Zurück zum Zitat Rossi M, Campbell KL, Johnson DW, Staton T, Vesey DA, Coombes JS et al (2014) Protein-bound uremic toxins, inflammation and oxidative stress: a cross-sectional study in stage 3–4 chronic kidney disease. Arch Med Res 45(4):309–317CrossRefPubMed Rossi M, Campbell KL, Johnson DW, Staton T, Vesey DA, Coombes JS et al (2014) Protein-bound uremic toxins, inflammation and oxidative stress: a cross-sectional study in stage 3–4 chronic kidney disease. Arch Med Res 45(4):309–317CrossRefPubMed
12.
Zurück zum Zitat Watanabe H, Miyamoto Y, Honda D, Tanaka H, Wu Q, Endo M et al (2013) p-Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase. Kidney Int 83:582–592CrossRefPubMed Watanabe H, Miyamoto Y, Honda D, Tanaka H, Wu Q, Endo M et al (2013) p-Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase. Kidney Int 83:582–592CrossRefPubMed
13.
Zurück zum Zitat Dou L, Sallée M, Cerini C, Poitevin S, Gondouin B, Jourde-Chiche N (2014) The cardiovascular effect of the uremic solute indole-3 acetic acid. J Am Soc Nephrol 26(4):876–887CrossRefPubMedPubMedCentral Dou L, Sallée M, Cerini C, Poitevin S, Gondouin B, Jourde-Chiche N (2014) The cardiovascular effect of the uremic solute indole-3 acetic acid. J Am Soc Nephrol 26(4):876–887CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Bolati D, Shimizu H, Yisireyili M, Nishijima F, Niwa T (2013) Indoxyl sulfate, a uremic toxin, downregulates renal expression of Nrf2 through activation of NF-kappaB. BMC Nephrol 4(14):56CrossRef Bolati D, Shimizu H, Yisireyili M, Nishijima F, Niwa T (2013) Indoxyl sulfate, a uremic toxin, downregulates renal expression of Nrf2 through activation of NF-kappaB. BMC Nephrol 4(14):56CrossRef
15.
Zurück zum Zitat Pedruzzi LM, Stockler-Pinto MB Jr, Leite M, Mafra D (2012) Nrf2-keap1 system versus NF-kappaB: the good and the evil in chronic kidney disease? Biochimie 94:2461–2466CrossRefPubMed Pedruzzi LM, Stockler-Pinto MB Jr, Leite M, Mafra D (2012) Nrf2-keap1 system versus NF-kappaB: the good and the evil in chronic kidney disease? Biochimie 94:2461–2466CrossRefPubMed
16.
Zurück zum Zitat Leal VO, Saldanha JF, Stockler-Pinto MB, Cardozo LF, Santos FR, Albuquerque AS et al (2015) NRF2 and NF-κB mRNA expression in chronic kidney disease: a focus on nondialysis patients. Int Urol Nephrol 47(12):1985–1989CrossRefPubMed Leal VO, Saldanha JF, Stockler-Pinto MB, Cardozo LF, Santos FR, Albuquerque AS et al (2015) NRF2 and NF-κB mRNA expression in chronic kidney disease: a focus on nondialysis patients. Int Urol Nephrol 47(12):1985–1989CrossRefPubMed
17.
Zurück zum Zitat Daugirdas JT (1993) Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol 4:1205–1213PubMed Daugirdas JT (1993) Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol 4:1205–1213PubMed
18.
Zurück zum Zitat de Loor H, Meijers BK, Meyer TW, Bammens B, Verbeke K, Dehaen W, Evenepoiel P (2009) Sodium octanoate to reverse indoxyl sulfate and p-cresyl sulfate albumin binding in uremic and normal serum during sample preparation followed by fluorescence liquid chromatography. J Chromatogr A 1216(22):4684–4688CrossRefPubMed de Loor H, Meijers BK, Meyer TW, Bammens B, Verbeke K, Dehaen W, Evenepoiel P (2009) Sodium octanoate to reverse indoxyl sulfate and p-cresyl sulfate albumin binding in uremic and normal serum during sample preparation followed by fluorescence liquid chromatography. J Chromatogr A 1216(22):4684–4688CrossRefPubMed
19.
Zurück zum Zitat Meert N, Schepers E, Glorieux G, Landschoot MV, Goeman JL, Waterloos MA et al (2012) Novel method for simultaneous determination of p-cresylsulphate and p-cresylglucuronide: clinical data and pathophysiological implications. Nephrol Dial Transplant 27(6):2388–2396CrossRefPubMed Meert N, Schepers E, Glorieux G, Landschoot MV, Goeman JL, Waterloos MA et al (2012) Novel method for simultaneous determination of p-cresylsulphate and p-cresylglucuronide: clinical data and pathophysiological implications. Nephrol Dial Transplant 27(6):2388–2396CrossRefPubMed
20.
Zurück zum Zitat Boelaert J, Lynen F, Glorieux G, Eloot S, Van Landschoot M, Waterloos MA et al (2013) A novel UPLC-MS-MS method for simultaneous determination of seven uremic retention toxins with cardiovascular relevance in chronic kidney disease patients. Anal Bioanal Chem 405(6):1937–1947CrossRefPubMed Boelaert J, Lynen F, Glorieux G, Eloot S, Van Landschoot M, Waterloos MA et al (2013) A novel UPLC-MS-MS method for simultaneous determination of seven uremic retention toxins with cardiovascular relevance in chronic kidney disease patients. Anal Bioanal Chem 405(6):1937–1947CrossRefPubMed
21.
Zurück zum Zitat Grotto D, Santa Maria LD, Boeira S, Valentini J, Charão MF, Moro AM et al (2007) Rapid quantification of malondialdehyde in plasma by high performance liquid chromatography-visible detection. J Pharm Biomed Anal 43(2):619–624CrossRefPubMed Grotto D, Santa Maria LD, Boeira S, Valentini J, Charão MF, Moro AM et al (2007) Rapid quantification of malondialdehyde in plasma by high performance liquid chromatography-visible detection. J Pharm Biomed Anal 43(2):619–624CrossRefPubMed
22.
Zurück zum Zitat Neirynck N, Vanholder R, Schepers E, Eloot S, Pletinck A, Glorieux G (2013) An update on uremic toxins. Int Urol Nephrol 45:139–150CrossRefPubMed Neirynck N, Vanholder R, Schepers E, Eloot S, Pletinck A, Glorieux G (2013) An update on uremic toxins. Int Urol Nephrol 45:139–150CrossRefPubMed
23.
Zurück zum Zitat Liabeuf S, Barreto DV, Barreto FC, Meert N, Glorieux G, Schepers E (2010) Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease. Nephrol Dial Transplant 25(4):1183–1191CrossRefPubMed Liabeuf S, Barreto DV, Barreto FC, Meert N, Glorieux G, Schepers E (2010) Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease. Nephrol Dial Transplant 25(4):1183–1191CrossRefPubMed
24.
Zurück zum Zitat Lin CJ, Wu V, Wu PC (2015) Meta-analysis of the associations of p-cresyl sulfate (PCS) and indoxyl sulfate (IS) with cardiovascular events and all-cause mortality in patients with chronic renal failure. PLoS ONE 10(7):e0132589CrossRefPubMedPubMedCentral Lin CJ, Wu V, Wu PC (2015) Meta-analysis of the associations of p-cresyl sulfate (PCS) and indoxyl sulfate (IS) with cardiovascular events and all-cause mortality in patients with chronic renal failure. PLoS ONE 10(7):e0132589CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Ito S, Osaka M, Higuchi Y, Nishijima F, Ishii H, Yoshida M (2010) Indoxyl sulfate induces leukocyte-endothelial interactions through up-regulation of E-selectin. J Biol Chem 285(50):38869–38875CrossRefPubMedPubMedCentral Ito S, Osaka M, Higuchi Y, Nishijima F, Ishii H, Yoshida M (2010) Indoxyl sulfate induces leukocyte-endothelial interactions through up-regulation of E-selectin. J Biol Chem 285(50):38869–38875CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Adelibieke Y, Shimizu H, Muteliefu G, Bolati D, Niwa T (2012) Indoxyl sulfate induces endothelial cell senescence by increasing reactive oxygen species production and p53 activity. J Ren Nutr 22(1):86–89CrossRefPubMed Adelibieke Y, Shimizu H, Muteliefu G, Bolati D, Niwa T (2012) Indoxyl sulfate induces endothelial cell senescence by increasing reactive oxygen species production and p53 activity. J Ren Nutr 22(1):86–89CrossRefPubMed
27.
Zurück zum Zitat Adesso S, Popolo A, Bianco G, Sorrentino R, Pinto A, Autore G et al (2013) The uremic toxin indoxyl sulphate enhances macrophage response to LPS. PLoS One 8(9):e76778.30CrossRef Adesso S, Popolo A, Bianco G, Sorrentino R, Pinto A, Autore G et al (2013) The uremic toxin indoxyl sulphate enhances macrophage response to LPS. PLoS One 8(9):e76778.30CrossRef
28.
Zurück zum Zitat Shimizu H, Yisireyli M, Higashiyama Y, Nishijima F, Niwa T (2013) Indoxyl sulfate upregulates renal expression of ICAM-1 via production of ROS and activation of NF-kappa b and p53 in proximal tubular cell. Life Sci 92(2):1143–1148CrossRef Shimizu H, Yisireyli M, Higashiyama Y, Nishijima F, Niwa T (2013) Indoxyl sulfate upregulates renal expression of ICAM-1 via production of ROS and activation of NF-kappa b and p53 in proximal tubular cell. Life Sci 92(2):1143–1148CrossRef
29.
Zurück zum Zitat Masai N, Tatebe J, Yoshino G, Morita T (2010) Indoxyl sulfate stimulates monocyte chemoattractant protein-1 expression in human umbilical vein endothelial cells by inducing oxidative stress through activation of the NADPH oxidase-nuclear factor-kB pathway. Circ J 74:2216–2224CrossRefPubMed Masai N, Tatebe J, Yoshino G, Morita T (2010) Indoxyl sulfate stimulates monocyte chemoattractant protein-1 expression in human umbilical vein endothelial cells by inducing oxidative stress through activation of the NADPH oxidase-nuclear factor-kB pathway. Circ J 74:2216–2224CrossRefPubMed
30.
Zurück zum Zitat Gelasco AK, Raymond JR (2006) Indoxyl sulfate induces complex redox alterations in mesangial cells. Am J Physiol Ren Physiol 290:1551–1558CrossRef Gelasco AK, Raymond JR (2006) Indoxyl sulfate induces complex redox alterations in mesangial cells. Am J Physiol Ren Physiol 290:1551–1558CrossRef
31.
Zurück zum Zitat Goundouin B, Cerini C, Dou L, Salée M, Durvai-Sabatier A, Pletinck A et al (2013) Indolic uremic solutes increase tissue factor production in endothelial cells by the aryl hydrocarbon receptor pathway. Kidney Int 84:733–744CrossRef Goundouin B, Cerini C, Dou L, Salée M, Durvai-Sabatier A, Pletinck A et al (2013) Indolic uremic solutes increase tissue factor production in endothelial cells by the aryl hydrocarbon receptor pathway. Kidney Int 84:733–744CrossRef
32.
Zurück zum Zitat Lekawanvijit S, Adrahtas A, Kelly DJ, Kompa AR, Wang BH, Krum H (2010) Does indoxyl sulfate, a uraemic toxin, have direct effects on cardiac fibroblasts and myocytes? Eur Heart J 31:1771–1779CrossRefPubMed Lekawanvijit S, Adrahtas A, Kelly DJ, Kompa AR, Wang BH, Krum H (2010) Does indoxyl sulfate, a uraemic toxin, have direct effects on cardiac fibroblasts and myocytes? Eur Heart J 31:1771–1779CrossRefPubMed
33.
Zurück zum Zitat Jung KA, Kwak MK (2010) The Nrf2 system as a potential target for the development of indirect antioxidants. Molecules 15(10):7266–7291CrossRefPubMed Jung KA, Kwak MK (2010) The Nrf2 system as a potential target for the development of indirect antioxidants. Molecules 15(10):7266–7291CrossRefPubMed
34.
Zurück zum Zitat Singh S, Vrishni S, Singh BK, Rahman I, Kakkar P (2010) Nrf2-ARE stress response mechanism: a control point in oxidative stress-mediated dysfunctions and chronic inflammatory diseases. Free Radic Res 44(11):1267–1288CrossRefPubMed Singh S, Vrishni S, Singh BK, Rahman I, Kakkar P (2010) Nrf2-ARE stress response mechanism: a control point in oxidative stress-mediated dysfunctions and chronic inflammatory diseases. Free Radic Res 44(11):1267–1288CrossRefPubMed
35.
Zurück zum Zitat Baird L, Dinkova-Kostov AT (2011) The cytoprotective role of the Keap1-Nrf2 pathway. Arch of Toxicol 85(4):241–272CrossRef Baird L, Dinkova-Kostov AT (2011) The cytoprotective role of the Keap1-Nrf2 pathway. Arch of Toxicol 85(4):241–272CrossRef
36.
Zurück zum Zitat Kim HJ, Vaziri ND (2010) Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure. Am J Physiol Ren Physiol 98(3):662–671CrossRef Kim HJ, Vaziri ND (2010) Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure. Am J Physiol Ren Physiol 98(3):662–671CrossRef
37.
Zurück zum Zitat Lau WL, Liu SM, Pahlevan S, Yuan J, Khazaeli M, Ni Z et al (2014) Role of Nrf2 dysfunction in uremia-associated intestinal inflammation and epithelial barrier disruption. Dig Dis Sci 60(5):1215–1222CrossRefPubMed Lau WL, Liu SM, Pahlevan S, Yuan J, Khazaeli M, Ni Z et al (2014) Role of Nrf2 dysfunction in uremia-associated intestinal inflammation and epithelial barrier disruption. Dig Dis Sci 60(5):1215–1222CrossRefPubMed
38.
Zurück zum Zitat Koppe L, Mafra D, Fouque D (2015) Probiotics and chronic kidney disease. Kidney Int 88(5):958–966CrossRefPubMed Koppe L, Mafra D, Fouque D (2015) Probiotics and chronic kidney disease. Kidney Int 88(5):958–966CrossRefPubMed
39.
Zurück zum Zitat Saito H, Yoshimura M, Saigo C, Komori M, Nomura Y, Yamamoto Y et al (2014) Hepatic sulfotransferase as a nephropreventing target by suppression of the uremic toxin indoxyl sulfate accumulation in ischemic acute kidney injury. Toxicol Sci 141(1):206–217CrossRefPubMedPubMedCentral Saito H, Yoshimura M, Saigo C, Komori M, Nomura Y, Yamamoto Y et al (2014) Hepatic sulfotransferase as a nephropreventing target by suppression of the uremic toxin indoxyl sulfate accumulation in ischemic acute kidney injury. Toxicol Sci 141(1):206–217CrossRefPubMedPubMedCentral
40.
Zurück zum Zitat Gao H, Liu S (2017) Role of uremic toxin indoxyl sulfate in the progression of cardiovascular disease. Life Sci 185:23–29CrossRefPubMed Gao H, Liu S (2017) Role of uremic toxin indoxyl sulfate in the progression of cardiovascular disease. Life Sci 185:23–29CrossRefPubMed
Metadaten
Titel
From bench to the hemodialysis clinic: protein-bound uremic toxins modulate NF-κB/Nrf2 expression
verfasst von
Milena B. Stockler-Pinto
Christophe O. Soulage
Natália A. Borges
Ludmila F. M. F. Cardozo
Carla J. Dolenga
Lia S. Nakao
Roberto Pecoits-Filho
Denis Fouque
Denise Mafra
Publikationsdatum
18.11.2017
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 2/2018
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-017-1748-y

Weitere Artikel der Ausgabe 2/2018

International Urology and Nephrology 2/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.